Feature | November 10, 2010 | Dave Fornell

Vascular Imaging Systems

Dose Lowering, Navigation Aids Among Top Trends in Angiography

This article appeared as an introduction to the Vascular Imaging Systems comparison chart.

Lowering radiation dose and improving navigation abilities of angiography systems have been among the top priorities of manufacturers over the past year. Another big trend is integration of angiography systems in hybrid cath lab/operating rooms (ORs) as collaboration between surgeons and interventionalists improves with increasingly less-invasive procedures. Following are some of the innovations in angiography technology that have been introduced in the past year.

CT-Like Imaging
An important step forward has been the creation of computed tomography (CT)-like images in the cath lab using rotational angiography. Originally introduced by GE in 1997, most angiography manufacturers created their own systems, where the C-arm makes a rotation around the patient to create a 3-D image dataset. The image can be used as an overlay for better navigation, anatomical reference and to help view device positioning. The images also overcome a shortcoming of angiography, which does not show the true lumen wall in vessels with stenosis.

The Siemens Artis zeego delivers large-volume syngo DynaCT, offering CT-like slice images of the heart in motion and an ECG-triggering option. Philips’ 3-D coronary angiography (3-D-CA) imaging creates a 3-D model of the coronary vessel tree. The cardiac imaging volume can also be used to select the optimal viewing angle throughout the examination. The system will move the C-arm into the selected viewing angle automatically so additional dose is not used to reposition the arm.

Advanced Visualization Aids Navigation
At RSNA 2009, GE introduced new visualization tools for its Innova 4100IQ. With the Advantage Workstation VolumeShare 4, it uses software to provide precise anatomical detail. It includes subtracted 3-D, which quickly visualizes vessels without having to remove surrounding bone, tissue and implanted devices. It also allows side-by-side nonsubtracted 3-D, subtracted 3-D or 3-D mask images to compare, merge and analyze complementary images.

GE’s Blended Roadmap helps navigate complex anatomy by superimposing any angiography or InnovaBreeze bolus image with fluoroscopy using the table-side controls. Registration tools correct for patient movement and help improve vessel and anatomy visualization.
Philip’s StentBoost stent visualization feature helps better define the stent in relation to the vessel wall for more accurate placement. Philips’ Allura Xper FD20 offers the MR/CT Roadmap feature to synchronize live fluoroscopy with previously acquired MRA/CTA datasets. Philips said this helps reduce contrast media use and X-ray dose compared to standard 2-D or 3-D navigation.

Veran is collaborating with GE to integrate its ig4 multimodality navigation system with Innova. The ig4 uses electromagnetic localization and image fusion to display an interventional instrument on a computer monitor that also displays a CT-based model of the target organ.

Lowering the Dose
Progress has been made in lowering X-ray dose with technical enhancements. Software now helps record and track exposure levels. Technologies were also created to allow more efficient use of the X-rays and contrast.

Innova’s dose-efficient technology, powered by the AutoEx control system, automatically and continuously adapts to customize radiation dose for each patient and procedure to help keep image quality and patient dose at optimum levels. It can reduce patient dose by as much as 40 percent without compromising image quality.

Philips offers similar dose-lowering features with its iDose technology. Its XperSwing feature also provides rotational angiography that reduces both X-ray dose and contrast usage. The C-arm rotates on a dual-axis, allowing a curved trajectory, so several anatomical views can be imaged in a single run. Conventional C-arms move along one axis, so several runs might be necessary.

For clinicians, Philips introduced DoseAware. It offers a live tracking display of clinician X-ray dose and warns them when they enter the radiation field. It records the information and generates exposure reports.

Table Technology
Angiographic system tables have become more versatile to allow better access to the patient and better positioning for optimal imaging. They are also being designed for use in hybrid cath labs. The newest generation of tables is motorized for accurate positioning and has the ability to tilt and pan.

GE’s InnovaIQ Table features auto-positioning so the patient can be brought back into repeatable clinical positioning for 2-D and 3-D acquisitions. It also allows for fast transitions from one complex position to another.

Toshiba’s CAT-880B hybrid suite table offers head-to-toe tilting and side-to-side cradling to meet the needs of both interventionalists and surgeons. The table features a 550-pound table weight limit, allows for angulations of up to 16 degrees in all four directions, and offers one of the lowest table-top heights.

Siemens’ Artis zeego robotic-assisted positioning enables variable working heights. It is also configured with specific parking positions for the C-arm in hybrid rooms to maximize room space during patient transfers.

Related Content

Evaluation of the lung apices using computed tomography angiography of the head and neck during acute ischemic stroke (AIS) can provide the first objective opportunity to screen for coronavirus disease 2019 (COVID-19)

Image courtesy of the American Heart Association

News | CT Angiography (CTA) | October 30, 2020
October 30, 2020 — ...
José Obeso, MD, PhD, (left) of of the Centro Integral de Neurociencias (HM CINAC) in Madrid and Nir Lipsman, MD, PhD, (right) of Sunnybrook Health Sciences Centre in Toronto. Each doctor is leading a clinical trial using focused ultrasound to target the striatum in patients with Parkinson's disease.

José Obeso, MD, PhD, (left) of of the Centro Integral de Neurociencias (HM CINAC) in Madrid and Nir Lipsman, MD, PhD, (right) of Sunnybrook Health Sciences Centre in Toronto. Each doctor is leading a clinical trial using focused ultrasound to target the striatum in patients with Parkinson's disease.

News | Focused Ultrasound Therapy | October 30, 2020
October 30, 2020 — A team of researchers in Madrid, Spain, and another team in Toronto, Canada, are the first in the
This study found cardiac MRI gadolinium-based contrast agents are safe for patient use. Overall, there were only 556 acute adverse effects in 145,855 contrast-enhanced MRIs, with only 47 being classified as severe. 

This study found cardiac MRI gadolinium-based contrast agents are safe for patient use. Overall, there were only 556 acute adverse effects in 145,855 contrast-enhanced MRIs, with only 47 being classified as severe. 

Feature | Magnetic Resonance Imaging (MRI) | October 29, 2020
October 29, 2020 — Contrast agents used to improve views of the heart on magnetic resonance imaging (MRI) carry a ver
Kaplan-Meier curves for all-cause mortality in patients with versus without myocardial injury (Panel A) and in patients with versus without myocardial injury according to the presence or absence of major echocardiographic abnormalities (Panel B). *Includes wall motion abnormalities, global left ventricular dysfunction, diastolic dysfunction, right ventricular dysfunction and presence of pericardial effusion. Event rates are censored at 20 days from hospital admission. Images courtesy of Mount Sinai Health S

Kaplan-Meier curves for all-cause mortality in patients with versus without myocardial injury (Panel A) and in patients with versus without myocardial injury according to the presence or absence of major echocardiographic abnormalities (Panel B). *Includes wall motion abnormalities, global left ventricular dysfunction, diastolic dysfunction, right ventricular dysfunction and presence of pericardial effusion. Event rates are censored at 20 days from hospital admission. Images courtesy of Mount Sinai Health System

News | Ultrasound Imaging | October 28, 2020
October 28, 2020 — Card...
A sonographer at Northwestern Memorial Hospital using the Caption Health AI to optimize ultrasound imaging.

A sonographer at Northwestern Memorial Hospital using the Caption Health AI to optimize ultrasound imaging.

News | Ultrasound Imaging | October 28, 2020
October 28, 2020 — Northwestern Memorial Hospital is the first hospital in the United States to purchase Caption Heal
Ceiling-mounted X-ray system includes MyExam Companion intelligent user interface to guide technologist through exam workflow
News | X-Ray | October 26, 2020
October 26, 2020 — Siemens Healthineers has announced the Food and Drug Administration (FDA) clearance of the...
This illustration show the complexity of the data obtained from one single patient with moderate/severe traumatic brain injury. Different imaging approaches and techniques have their own unique sensitivity in assessing different aspects of neuroanatomy and neuropathology. What can be seen on images also changes with time since injury. Data from comprehensive clinical and functional assessments using a range of other tools is also important for evaluating patient outcome. Through data harmonization and large

This illustration show the complexity of the data obtained from one single patient with moderate/severe traumatic brain injury. Different imaging approaches and techniques have their own unique sensitivity in assessing different aspects of neuroanatomy and neuropathology. What can be seen on images also changes with time since injury. Data from comprehensive clinical and functional assessments using a range of other tools is also important for evaluating patient outcome. Through data harmonization and large-scale analyses of data combined across multiple research sites, the ENIGMA Brain Injury will develop and test methods and procedures for making sense of the complexity in this data. Images courtesy of Olsen et al., Brain Imaging and Behavior, 2020

News | Magnetic Resonance Imaging (MRI) | October 23, 2020
October 23, 2020 — Trau...
A, Initial conventional axial CT image shows no noticeable lung damage (within red box) in right upper lobe. B, Electron density spectral CT image obtained at same time as image in A shows lesions (within red box) in right upper lobe. C, Follow-up conventional axial chest CT image obtained 5 days after images in A and B confirm presence of lesions (within red box) in right upper lobe.

A, Initial conventional axial CT image shows no noticeable lung damage (within red box) in right upper lobe. B, Electron density spectral CT image obtained at same time as image in A shows lesions (within red box) in right upper lobe. C, Follow-up conventional axial chest CT image obtained 5 days after images in A and B confirm presence of lesions (within red box) in right upper lobe. Image courtesy of the American Roentgen Ray Society (ARRS), American Journal of Roentgenology (AJR)

News | Coronavirus (COVID-19) | October 22, 2020
October 22, 2020 — According to an open-...
The fMRI hyperscanning environment.

(A) The fMRI hyperscanning environment. The clinician (1) and patient (2) were positioned in two different 3T MRI scanners. An audio-video link enabled online communication between the two scanners (3), and video images were used to extract frame-by-frame facial expression metrics. During simultaneous acquisition of blood oxygen level–dependent (BOLD)–fMRI data, the clinician used a button box (4) to apply electroacupuncture (EA) treatment (real/sham, double-blind) to the patient (5) to alleviate evoked pressure pain to the leg (6; Hokanson cuff inflation). Pain and affect related to the treatment were rated after each trial. (B) Study overview. After an initial behavioral visit, each individual participated in a Clinical-Interaction (hyperscan preceded by a clinical intake) and No-Interaction condition (hyperscan without a preceding intake), in a counterbalanced order, with two different partners. (C) Experimental protocol. Each hyperscan was composed of 12 repeated trials (four verum EA, four sham EA, and four no treatment) in a pseudo-randomized order. After a resting period (far left), both participants were shown a visual cue to indicate whether the next pain stimulus would be treated (green frame) or not treated (red frame) by the clinician. These cues prompted clinicians prepare to either apply or not apply treatment while evoking corresponding anticipation for the patient. Following the anticipation cue, moderately painful pressure pain was applied to the patient’s left leg, while the clinician applied or did not apply treatment, respectively. After another resting period, participants rated pain (patients), vicarious pain (clinicians), and affect (both) using a visual analog scale (VAS).

News | Clinical Trials | October 22, 2020
October 22, 2020 — The potential impact of the patient-clinician relationship on a patient's response to treatment is